PPT-Idiopatische Lungenfibrose IPF

IPF S2kLeitline basiert Präsentation im Rahmen von AT8 Ausbildung Mai 2019 I diopathische p ulmonale F ibrose was ist das eigentlich Langsam fortschreitende Erkrankung des Lungeninterstitiums. Case Presentation: Familial IPF. 56-year-old Hispanic female with a family history of aortic aneurysm underwent a routine chest CT to assess her aorta. No respiratory symptoms. Medical history . h/o SVT. (ILD). Mike McFarlane (CT1). 12/5/12. SLIME. What we’ll cover. Definition. Different types of ILD. Pathophysiology. Presentation. Investigations. Management. Prognosis. Clinical Scenario. Summary. What we won’t.... Comorbidities and Complications. FACULTY. Title. Affiliation. Learning Objectives. Identify approaches to IPF management that are covered in current . guidelines. , taking into account the strength of relevant . Overview of IPF. Overview of IPF (cont). The Role of HRCT in Assessing IPF. HRCT Techniques. Early HRCT Findings in IPF. Hypersensitivity Pneumonitis. HRCT Features and Distribution in Lungs. Definite UIP (All 4 Features). PULMONARY FIBROSIS MANAGEMENT STRATEGIES I. NOVEMBER 13, 2015. Managing comorbidity. Disclosures. . Scientific Advisory Board and speaker’s fees. Biogen. Idec, . Boehringer. . Ingelheim. ,. Gilead, . – . The need for early recognition and referral. PRC-2128. It can be difficult to separate idiopathic pulmonary fibrosis (IPF) from other conditions. IPF is a rare but fatal lung disease, with a lower survival rate than many common malignancies. Educational Activity Learning Objective. Upon completion of this course, the participants should be able to:. Explain the considerations associated with clinical evaluation, imaging, and surgical . biopsy . Diagnosing Idiopathic Pulmonary Fibrosis. FACULTY. Title. Affiliation. Learning Objectives. Explain the considerations associated with . clinical evaluation, imaging, and . biopsy. , in terms of differentially diagnosing . 56-year-old Hispanic female with a family history of aortic aneurysm underwent a routine chest CT to assess her aorta. No respiratory symptoms. Medical history . h/o SVT. Type 2 diabetes mellitus. Hypertension. The . Next Steps in Individualizing Treatment. Learning Objectives. As a result of attending this activity, participants should be able to. :. Select . appropriate therapies that reflect current evidence and/ or widely accepted guidelines that are individualized to patients . DEFINITIONS USED IN SURVEY. 2. Direct-to-Pharmacy (DTP): . In the DTP distribution model pharmaceutical manufacturers deliver their medicinal products directly to the pharmacies through one or more logistic service providers. . (. P. ulmonary Fibrosis . I. dentification: . L. essons for . O. ptimizing . T. reatment) is a national education initiative driven by The France Foundation, an ACCME-accredited . provider. Education focuses . for Fibrosis & Oncology. Corporate Presentation – April 2021. Disclaimer. This document has been prepared by Nuformix plc (the "Company") and is being . made available for the sole purpose of providing the recipients with background information about the Company. It. Department. of . Diseases. of the . Thorax. , Ospedale GB . Morgagni. , Forlì (I). Department. of . Respiratory. . Diseases. & . Allergy. , . Aarhus. . University. Hospital, . Aarhus. (DK).